Open to and included for all attendees.

Four panelists will present different precision medicine approaches for targeting osteosarcoma, with a panel discussion led by Dr. Troy McEachron from the NCI.

Four panelists will discuss what we can learn from osteosarcoma blood and tissue samples including best practices for optimizing and allocating tissue samples, and the latest on liquid biopsies for osteosarcoma, with a panel discussion led by Dr. Alanna Church from Dana-Farber Cancer Institute. 

Included for all attendees.

Four panelists will present on supportive care strategies and survivorship issues such as symptom management, social emotional care, and transitioning to survivorship, with a discussion led by Dr. Noah Federman of UCLA.

Six panelists will present on initiatives to collect data on osteosarcoma and other childhood cancers and discuss issues like engaging the patient community, data harmonization and possibilities for clinical application. Dr. Richard Gorlick from MD Anderson Cancer Center will lead the panel discussion.

Join us in congratulating our 2022 Outsmarting Osteosarcoma grant recipients as we record this exciting accomplishment with photos and a check presentation from our Family Funds who make these grants possible.

All attendees are invited. Thank you to BTG Speciality Pharmaceutical for hosting this event. Hors d'oeuvres and non-alcoholic drinks will be provided.  A cash bar will be available.

After a fun day at the Safari Park, we will stop by the famous In n Out for burgers and fries on our way home.

Included for all attendees.

Included for all attendees.

Six panelists will present different approaches to harnessing the immune system to treat osteosarcoma, with a panel discussion led by Dr. Alex Huang of Case Western University/University Hospitals Rainbow Babies and Children's Hospital. 

Dr. Lee Helman will provide an overview on the work of the Osteosarcoma Institute, including clinical trials, translation work, correlative science, biotech involvement, and new technology exploration, and OSI Connect.

MIB Agents Outsmarting Osteosarcoma 2022 grant recipients will provide an overview of funded studies.

Four panelists will present different strategies and studies to inform local control best practices, with a panel discussion led by Dr. Jane Yanagawa of UCLA.

Included for all attendees.

Four panelists will discuss protocols for existing therapies to decrease toxicities and improve quality of life, and explore leverage existing therapies for improved response, with a panel discussion led by Dr. Leo Mascarenhas from CHLA/USC.

Seven panelists will discuss clinical trials either in progress or about to open soon for osteosarcoma, with a panel discussion led by Dr. Michael Isakoff of Connecticut Children’s Hospital.

Seven panelists will discuss clinical trials either in progress or about to open soon for osteosarcoma, with a panel discussion led by Dr. Michael Isakoff of Connecticut Children’s Hospital.

Healing Hearts was created by grieving parents who themselves needed a haven of love and comfort along with the hope of healing. While we acknowledge that our hearts will never heal after the loss of a child, we want our scars to remind us that we can experience joy alongside sadness.

Together, we support each other in creating a life worth living, for and with our children.

This, and every MIB Agents program, is free of charge, thanks to generous donors who Make it Better.